'Increased risk' of rare nerve disorder after J&J Covid vaccine: US
Washington (AFP) - The US Food and Drug Administration updated its warning labels Monday for the Johnson & Johnson Covid-19 vaccine to include information about an observed "increased risk" of a rare neurological disorder called Guillain-Barre Syndrome (GBS). The news is a further blow for the company, which was granted an emergency use authorization for its shot in February but has played a minor role in America's coronavirus immunization campaign. Based on analysis of a federal vaccine safety monitoring system, officials have identified 100 preliminary reports of GBS after approximately 12.5...